As the global economy mends, the 2021 growth of Budesonide Inhaler will have significant change from previous year. According to our researcher's latest study, the global Budesonide Inhaler market size is USD million in 2022 from USD 4389 million in 2021, with a change of % between 2021 and 2022. The global Budesonide Inhaler market size will reach USD 5555.1 million in 2028, growing at a CAGR of 3.4% over the analysis period.
The United States Budesonide Inhaler market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Budesonide Inhaler market, reaching US$ million by the year 2028. As for the Europe Budesonide Inhaler landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Budesonide Inhaler players cover AstraZeneca, Cosmo Pharmaceuticals, Teva Pharmaceutical, and Novartis, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Budesonide Inhaler market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Dry Powder
Suspension
Sprays
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
AstraZeneca
Cosmo Pharmaceuticals
Teva Pharmaceutical
Novartis
Mylan
Pfizer
Dr. Falk Pharma
Chiesi Farmaceutici
Orion Corporation
Cipla Limited
Bausch Health Companies
Takeda Pharmaceutical
Lupin Limited
Synmosa Biopharma Corporation
Lunan Better Pharmaceutical
Shanghai Sine Pharmaceutical Laboratories